AU Patent

AU2020287620B2 — Compositions and methods relating to erythrocytes with adhered particles

Assigned to Harvard University · Expires 2025-12-18 · 0y expired

What this patent protects

Provided herein are erythrocytes with polymeric particles (i.e., "backpacks") adhered that provide delivery of payload therapeutic agents to subjects administered these cells.

USPTO Abstract

Provided herein are erythrocytes with polymeric particles (i.e., "backpacks") adhered that provide delivery of payload therapeutic agents to subjects administered these cells.

Drugs covered by this patent

leuprolide-mesylate (LEUPROLIDE MESYLATE)

Patent Metadata

Patent number: AU2020287620B2
Jurisdiction: AU
Classification: —
Expires: 2025-12-18
Drug substance claim: No
Drug product claim: No
Assignee: Harvard University
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.